ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 696052 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 696052; 2) Community: the network communities that were significantly associated with the response to NSC 696052; 3) Molecule: the relationships between components within communities and NSC 696052; 4) MDR: the compounds that were significantly associated with the NSC 696052.

NSC Compound Enrichment Correlation
NSC 750335 (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.00663743932906076 0.24971374
NSC 94037 Mikanolide 0.00663743932906076 -0.062648595
NSC 243022 Cinerubin A hydrochloride 0.00663743932906085 -0.007867149
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.00663743932906085 0.0071088799
NSC 351907 MASTOPARAN 0.00663743932906085 0.0080969461
NSC 603831 Acteoside 0.00663743932906085 -0.39642211
NSC 606498 Camptothecin Derivative 0.00663743932906085 -0.071682952
NSC 609699 Topotecan hydrochloride 0.00663743932906085 -0.038990808
NSC 627669 Null 0.00663743932906085 0.037594131
NSC 639174 Camptothecin Derivative 0.00663743932906085 -0.067682133
Total:91  Current:14    [First] [Prev] [Next] [Last]